MedKoo Cat#: 596874 | Name: S 2613

Description:

WARNING: This product is for research use only, not for human or veterinary use.

S 2613 is a luminogenic peptide substrate.

Chemical Structure

S 2613
S 2613
CAS#84272-64-0

Theoretical Analysis

MedKoo Cat#: 596874

Name: S 2613

CAS#: 84272-64-0

Chemical Formula: C37H57N11O9

Exact Mass: 799.4341

Molecular Weight: 799.93

Elemental Analysis: C, 55.56; H, 7.18; N, 19.26; O, 18.00

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
S 2613; S-2613; S2613; Boc-ile-glu-piperidyl-gly-arg-isoluminol;
IUPAC/Chemical Name
tert-butyl ((6S,12S,15S,16S)-1-amino-6-carbamoyl-7-(1,4-dioxo-1,2,3,4-tetrahydrophthalazin-6-yl)-1-imino-16-methyl-8,11,14-trioxo-12-(3-oxo-3-(piperidin-1-yl)propyl)-2,7,10,13-tetraazaoctadecan-15-yl)carbamate
InChi Key
QHEGQPRUIQIAGT-KXDOSHFCSA-N
InChi Code
InChI=1S/C37H57N11O9/c1-6-21(2)29(44-36(56)57-37(3,4)5)34(55)43-25(14-15-27(49)47-17-8-7-9-18-47)33(54)42-20-28(50)48(26(30(38)51)11-10-16-41-35(39)40)22-12-13-23-24(19-22)32(53)46-45-31(23)52/h12-13,19,21,25-26,29H,6-11,14-18,20H2,1-5H3,(H2,38,51)(H,42,54)(H,43,55)(H,44,56)(H,45,52)(H,46,53)(H4,39,40,41)/t21-,25-,26-,29-/m0/s1
SMILES Code
N=C(N)NCCC[C@@H](C(N)=O)N(C(CNC([C@H](CCC(N1CCCCC1)=O)NC([C@H]([C@@H](C)CC)NC(OC(C)(C)C)=O)=O)=O)=O)C2=CC3=C(C(NNC3=O)=O)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 799.93 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Mazzei L, García IM, Cacciamani V, Benardón ME, Manucha W. WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction. Biocell. 2010 Dec;34(3):121-32. PubMed PMID: 21443142. 2: Lindahl U, Kolset SO, Bøgwald J, Osterud B, Seljelid R. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J. 1982 Aug 15;206(2):231-7. PubMed PMID: 7150243; PubMed Central PMCID: PMC1158578.